New Study by Fox Chase Researchers Indicates Neoadjuvant Chemotherapy Does Not Expedite Breast Cancer Treatment
March 03, 2020
March 03, 2020
PHILADELPHIA, Pennsylvania, March 3 -- The Fox Chase Cancer Center issued the following news release:
New research from Fox Chase Cancer Center indicates that starting chemotherapy before surgery does not expedite the start or completion of treatment for breast cancer as compared with performing surgery first, as some have previously believed.
"Increasingly, patients are given chemotherapy before they have surgery, which is called neoadjuvant chemotherapy. This is . . .
New research from Fox Chase Cancer Center indicates that starting chemotherapy before surgery does not expedite the start or completion of treatment for breast cancer as compared with performing surgery first, as some have previously believed.
"Increasingly, patients are given chemotherapy before they have surgery, which is called neoadjuvant chemotherapy. This is . . .